Towa Pharmaceutical Co., Ltd. (TYO:4553)

Japan flag Japan · Delayed Price · Currency is JPY
4,200.00
+50.00 (1.20%)
At close: Mar 6, 2026
43.74%
Market Cap 206.76B
Revenue (ttm) 269.92B
Net Income (ttm) 21.44B
Shares Out 49.23M
EPS (ttm) 435.61
PE Ratio 9.64
Forward PE 10.26
Dividend 80.00 (1.90%)
Ex-Dividend Date Mar 30, 2026
Volume 141,800
Average Volume 136,470
Open 4,090.00
Previous Close 4,150.00
Day's Range 4,040.00 - 4,200.00
52-Week Range 2,298.00 - 4,445.00
Beta -0.23
RSI 57.86
Earnings Date Feb 13, 2026

About Towa Pharmaceutical

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. It operates through two segments; Domestic and Overseas. The company provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from Tablets, Capsules, Injectable, Patches, eye drops, and other products. It also offers IT service related to healthcare; disease risk testing services; and quasi drugs. In ... [Read more]

Sector Healthcare
Founded 1951
Employees 4,788
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4553
Full Company Profile

Financial Performance

In fiscal year 2025, Towa Pharmaceutical's revenue was 259.59 billion, an increase of 13.89% compared to the previous year's 227.93 billion. Earnings were 18.99 billion, an increase of 17.39%.

Financial Statements

News

There is no news available yet.